Expression of oncogenes in gastric cancer tissue was evaluated with immunohistochemical staining methods using monoclonal antibodies to products of the oncogenes. Rates of expression in gastric cancer tissue were 50% for c-myc, 72% for c-erb B,, and 56% for c-Ha-rus oncogenes. Expression of these on
Enhanced expression of heregulin in c-erb B-2 and c-Ha-ras transformed mouse and human mammary epithelial cells
✍ Scribed by G. Mincione; C. Bianco; S. Kannan; G. Colletta; F. Ciardiello; M. Sliwkowski; Y. Yarden; N. Normanno; A. Pramaggiore; N. Kim; D.S. Salomon
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 978 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Heregulin P1 was found to stimulate the anchorage-dependent, serum-free growth of nontransformed human MCF-1 OA mammary epithelial cells. Unlike epidermal growth factor, transforming growth factor a, or amphiregulin, heregulin P I was also able to induce the anchorage-independent growth of MCF-1OA cells. In contrast, the anchorage-dependent, serum-free growth of c-Ha-ras or c-erb 6-2 transformed MCF-1 OA cells was unaffected by heregulin PI, whereas heregulin P I was able to stimulate the anchorage-independent growth of these cells. c-Ha-ras or c-erb 8-2 (c-neu) transformed MCF-1 OA or mouse NOG-8 mammary epithelial cells express elevated levels of 2.5, 5.0, 6.5, 6.8, and 8.5 kb heregulin mRNA transcripts and/or synthesize cell-associated 25, 29, 50, and 11 5 kDa isoforms of heregulin. Since the MCF-1 OA cells and transformants also express c-erb 8-3, these data suggest that endogenous heregulin might function as an autocrine growth factor for Ha-ras or erb 6-2 transformed mammary epithelial Cells.
📜 SIMILAR VOLUMES
## Abstract CCAAT/Enhancer binding proteins (C/EBPs) play important roles in the regulation of cell growth and differentiation. This study investigated the expression and function of C/EBPβ isoforms in the mouse mammary gland, mammary tumors, and a nontransformed mouse mammary epithelial cell line
## Abstract The ErbB family of receptor kinases is composed of four members: epidermal growth factor receptor (EGFR/ErbB1), ErbB2/neu, ErbB3, and ErbB4. Amplification of the ErbB2/neu is found in about 30% of breast cancer patients and is associated with a poor prognosis. Heregulin (HRG) activates
## Abstract “Loss of function” alterations in growth inhibitory signal transduction pathways are common in cancer cells. In this study, we show that growth arrest (GA) treatments—serum and growth factor withdrawal and growth inhibitory IL‐6 family cytokines (Interleukin‐6 and Oncostatin M (OSM))—in
## Abstract CCAAT/enhancer binding protein δ (C/EBPδ) plays a key role in mammary epithelial cell G~0~ growth arrest. C/EBPδ gene expression is down‐regulated in rodent mammary tumorigenesis and in human breast cancer, suggesting that “loss of function” alterations in C/EBPδ gene expression are com